SecSonar.com

MediWound Ltd. (MDWD)

MediWound Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

MediWound Ltd. (MDWD) is a Biotechnology company based in IL with a market capitalization of $157.8M. Revenue declined 16.1% year-over-year and free cash flow was negative at -$20M. This page tracks MDWD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 111 employees · IPO Mar 20, 2014

Valuation

Valuation & price

$16.41 · as of May 17, 2026 · -22.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.62

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$21.00$17.37$13.73Jul 25Dec 25Jul 26Jul 7, 25$19.27Jul 9, 25$20.69Jul 11, 25$20.03Jul 15, 25$20.01Jul 17, 25$20.05Jul 21, 25$20.07Jul 23, 25$21.00Jul 25, 25$20.33Jul 29, 25$19.80Jul 31, 25$18.64Aug 4, 25$18.37Aug 6, 25$18.41Aug 11, 25$18.72Aug 13, 25$18.75Aug 15, 25$18.10Aug 19, 25$17.35Aug 21, 25$17.39Aug 25, 25$17.25Aug 27, 25$17.00Aug 29, 25$16.70Sep 3, 25$16.57Sep 5, 25$16.29Sep 9, 25$16.29Sep 11, 25$19.06Sep 16, 25$17.09Sep 18, 25$17.25Sep 22, 25$17.95Sep 24, 25$18.02Sep 26, 25$17.89Sep 30, 25$18.02Oct 2, 25$17.07Oct 6, 25$17.71Oct 8, 25$17.63Oct 10, 25$18.17Oct 14, 25$18.47Oct 16, 25$19.47Oct 21, 25$18.65Oct 23, 25$18.50Oct 27, 25$18.40Oct 29, 25$18.07Oct 31, 25$18.33Nov 4, 25$17.90Nov 6, 25$18.03Nov 10, 25$17.98Nov 12, 25$18.22Nov 14, 25$18.25Nov 18, 25$18.28Nov 20, 25$16.86Nov 25, 25$18.20Nov 28, 25$17.92Dec 2, 25$17.35Dec 4, 25$17.98Dec 8, 25$18.51Dec 10, 25$19.17Dec 12, 25$19.05Dec 16, 25$18.77Dec 18, 25$18.84Dec 22, 25$18.62Dec 24, 25$18.88Dec 29, 25$18.66Jan 2, 26$18.42Jan 6, 26$18.79Jan 8, 26$19.30Jan 12, 26$17.23Jan 14, 26$17.04Jan 16, 26$16.25Jan 21, 26$17.07Jan 23, 26$17.70Jan 27, 26$18.03Jan 29, 26$17.61Feb 2, 26$18.10Feb 4, 26$17.62Feb 9, 26$17.95Feb 11, 26$17.25Feb 13, 26$17.27Feb 18, 26$17.12Feb 20, 26$17.87Feb 24, 26$17.57Feb 26, 26$17.52Mar 2, 26$17.41Mar 4, 26$17.60Mar 6, 26$17.03Mar 10, 26$17.37Mar 12, 26$16.58Mar 17, 26$17.40Mar 19, 26$16.97Mar 23, 26$16.88Mar 25, 26$16.98Mar 27, 26$15.05Mar 31, 26$16.11Apr 2, 26$16.81Apr 7, 26$16.97Apr 9, 26$17.77Apr 13, 26$17.65Apr 15, 26$17.25Apr 17, 26$17.72Apr 22, 26$17.08Apr 24, 26$16.72Apr 28, 26$16.56Apr 30, 26$16.50May 4, 26$17.26May 6, 26$17.37May 8, 26$16.57May 12, 26$16.13May 14, 26$16.80May 18, 26$16.40May 20, 26$16.89May 22, 26$16.58May 28, 26$14.56Jun 1, 26$13.82Jun 3, 26$13.73Jun 5, 26$14.18Jun 9, 26$14.30Jun 11, 26$14.09Jun 15, 26$13.95Jun 17, 26$14.20Jun 22, 26$13.96Jun 24, 26$14.85Jun 26, 26$15.19Jul 2, 26$15.16
$13.7352-week range$21.09
Loading valuation history…

Fundamentals

Key fundamentals

$157.8M

Market cap

-16.1%

Revenue growth (YoY)

19.2%

Gross margin

-$20M

Free cash flow (USD)

-$44.4M

Net debt

Net cash position

14.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.6MFY 2017$2.5MFY 2018$3.4MFY 2019$31.8MFY 2020$21.8MFY 2021$23.8MFY 2022$26.5MFY 2023$18.7MFY 2024$20.2MFY 2025$17.0M
$1.6M$17M

Free cash flow by year

2016 → 2025

FY 2016$-17.1MFY 2017$-17.5MFY 2018$-12.7MFY 2019$7.5MFY 2020$-7.8MFY 2021$-9.4MFY 2022$-12.4MFY 2023$-16.9MFY 2024$-19.9MFY 2025$-20.0M
-$17.1M-$20M

Gross margin by year

2021 → 2025

FY 202136.9%FY 202249.7%FY 202319.1%FY 202413.0%FY 202519.2%
36.9%19.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 27, 2026 (EPS $-0.23)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $84KSHAMIR NACHUM · Director · $84KJun 4, 2026Filing
  • Insider buyInsider Buy $50KFox David Morton · Director · $49.9KJun 2, 2026Filing
  • Insider buyInsider Buy $2KRubinstein Samuel · Director · $2.1KJun 1, 2026Filing
  • Annual reportAnnual Report FiledMay 27, 2026Filing
  • 6-K filingAnnual Shareholder Meeting ResultsMay 6, 2026Filing
  • 6-K filingBARDA Contract AwardApr 2, 2026Filing

Questions

Frequently asked questions

What is MediWound Ltd.'s market cap?

MediWound Ltd. (MDWD) has a market capitalization of $157.8M.

What is MDWD's P/E ratio?

A meaningful P/E ratio is not available for MDWD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MDWD's price-to-book (P/B) ratio?

MDWD trades at 3.62 times book value per share.

When did MediWound Ltd. last report earnings?

MDWD last reported earnings on May 27, 2026; the next date is not yet scheduled.

Are insiders buying MDWD stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at MediWound Ltd. in the last 90 days.

Same arena

Related companies in Biotechnology

UNCY

Unicycive Therapeutics, Inc.

$158.6M

VXRT

Vaxart, Inc.

$159.3M

ORMP

Oramed Pharmaceuticals Inc.

$162.9M

ADAG

Adagene Inc.

$152.5M

SPRO

Spero Therapeutics, Inc.

$163.3M

IVVD

Invivyd, Inc.

$151.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.